Black, Hispanic and female patients with ulcerative colitis were significantly less likely to undergo colectomy compared with ...
A new therapy that combines two existing drugs shows promise for patients with inflammatory bowel disease who have exhausted ...
New long-term data from Eli Lilly and Company (NYSE: LLY) show patients with moderately to severely active ulcerative colitis (UC) treated with Omvoh (mirikizumab-mrkz) achieved durable disease ...
Even with biologics changing the treatment paradigm for ulcerative colitis more than 2 decades ago, patients have a similar ...
LUCENT-3 trial open-label extension data show 63.5% of adults with ulcerative colitis administered mirikizumab (Omvoh) who ...
Lilly's Omvoh is the first and only IL-23p19 to demonstrate durable disease clearance in ulcerative colitis through four years: Indianapolis Wednesday, May 6, 2026, 09:00 Hrs [IST ...
A new combination drug therapy could help people with inflammatory bowel disease (IBD) for whom other medicines have stopped ...
Khaleej Times on MSN
King’s College Hospital London, Dubai launches new IBD service to deliver advanced, multidisciplinary care
King’s College Hospital Dubai has announced the launch of its new inflammatory bowel disease (IBD) service, a dedicated ...
Johnson & Johnson (NYSE:JNJ) reported new clinical results in immunology, MedTech, and neuropsychiatry. The company announced ...
We are pleased to welcome Rayna to the Cristcot team. She is an effective cross-functional leader with a proven track record building and scaling commercial operations, including integration to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results